Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Infectious Disorders Drug Targets|April 6, 2019
Therapeutic Exploitation of Viral InterferenceImre Kovesdi, Tibor BakacsCureus|September 30, 2022
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 VaccinationTibor Bakacs, Volker Sandig, Imre KovesdiHepatology, Medicine and Policy|October 6, 2018
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needsTibor Bakacs, Rifaat Safadi, Imre KovesdiPharmaceuticals (Basel, Switzerland)|June 1, 2023
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and AcyclovirTibor Bakacs, Volker Sandig, Imre KovesdiCureus|April 4, 2022
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New ModalityTibor Bakacs, Rifaat Safadi, László G Puskás, et al.Infectious Disorders Drug Targets|April 20, 2022
A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 PatientsTibor Bakacs, Volker Sandig, Shimon Slavin, et al.Cureus|January 13, 2022
Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case ReportTibor BakacsFrontiers in Immunology|March 13, 2026
Host-targeted oral avian vaccine virus demonstrates broad antiviral activity and safety in patientsTibor Bakacs, Konstantin ChumakovImmunobiology|February 2, 2015
Anti-CTLA-4 therapy may have mechanisms similar to those occurring in inherited human CTLA4 haploinsufficiencyTibor Bakacs, Jitendra N MehrishiScandinavian Journal of Immunology|March 11, 2026
Rethinking Immune Checkpoint Inhibition in CancerTibor Bakacs, Colin C AndersonPageof 5